Company: VRCA
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0000950170-25-070452
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
5 and December 31, 2024

     —

     —

     Common stock, $0.0001 par value; 200,000,000 authorized; 91,895,137 shares issued and 91,789,993 shares outstanding as of March 31, 2025 and 91,885,137 shares issued and 91,779,993 shares outstanding as of December 31, 2024

     9

     9

     Treasury stock, at cost, 105,144 shares as of March 31, 2025 and December 31, 2024

     —

     —

     Additional paid-in capital

     298,184

     297,158

     Accumulated deficit

     (316,769
     )

     (307,027
     )

     Total stockholders’ deficit

     (18,576
     )

     (9,860
     )

     Total liabilities and stockholders’ deficit
      
     $
     42,178

     $
     54,134

The accompanying notes are an integral part of these financial statements.